Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives
Cenk Tek Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA Abstract: Naltrexone, an opiate antagonist, and bupropion, a noradrenergic/dopaminergic antidepressant, have many effects on the reward systems of the brain. These medications impact eating behavior,...
| Hoofdauteur: | |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
Dove Medical Press
2016-05-01
|
| Reeks: | Patient Preference and Adherence |
| Onderwerpen: | |
| Online toegang: | https://www.dovepress.com/naltrexone-hcibupropion-hci-for-chronic-weight-management-in-obese-adu-peer-reviewed-article-PPA |